EdgarLookup

THEGLOBE COM INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that THEGLOBE COM INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $0 Apr 1, 2026
FY2025 Dec 31, 2024 $0 Apr 1, 2026
FY2024 Dec 31, 2023 $0 Mar 20, 2025
FY2023 Dec 31, 2022 $0 Mar 15, 2024
FY2022 Dec 31, 2021 $0 Mar 28, 2023
FY2021 Dec 31, 2020 $0 Mar 24, 2022
FY2020 Dec 31, 2019 $0 Mar 26, 2021
FY2019 Dec 31, 2018 $0 Mar 27, 2020
FY2018 Dec 31, 2017 $0 Mar 29, 2019
FY2017 Dec 31, 2016 $0 Mar 30, 2018

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($226.2K) Apr 1, 2026
FY2025 Dec 31, 2024 ($204.9K) Apr 1, 2026
FY2024 Dec 31, 2023 ($191.7K) Mar 20, 2025
FY2023 Dec 31, 2022 ($184.6K) Mar 15, 2024
FY2022 Dec 31, 2021 ($194.8K) Mar 28, 2023
FY2021 Dec 31, 2020 ($163.8K) Mar 24, 2022
FY2020 Dec 31, 2019 ($211.4K) Mar 26, 2021
FY2019 Dec 31, 2018 ($306.5K) Mar 27, 2020
FY2018 Dec 31, 2017 ($395.2K) Mar 29, 2019
FY2017 Dec 31, 2016 ($388.5K) Mar 30, 2018

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($132.2K) Apr 1, 2026
FY2025 Dec 31, 2024 ($127.0K) Apr 1, 2026
FY2024 Dec 31, 2023 ($116.7K) Mar 20, 2025
FY2023 Dec 31, 2022 ($120.3K) Mar 15, 2024
FY2022 Dec 31, 2021 ($141.9K) Mar 28, 2023
FY2021 Dec 31, 2020 ($118.2K) Mar 24, 2022
FY2020 Dec 31, 2019 ($177.6K) Mar 26, 2021
FY2019 Dec 31, 2018 ($297.4K) Mar 27, 2020
FY2018 Dec 31, 2017 ($330.8K) Mar 29, 2019
FY2017 Dec 31, 2016 ($333.4K) Mar 30, 2018

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($127.1K) Apr 1, 2026
FY2025 Dec 31, 2024 ($121.4K) Apr 1, 2026
FY2024 Dec 31, 2023 ($113.7K) Mar 20, 2025
FY2023 Dec 31, 2022 ($155.6K) Mar 15, 2024
FY2022 Dec 31, 2021 ($106.3K) Mar 28, 2023
FY2021 Dec 31, 2020 ($125.2K) Mar 24, 2022
FY2020 Dec 31, 2019 ($172.7K) Mar 26, 2021
FY2019 Dec 31, 2018 ($294.9K) Mar 27, 2020
FY2018 Dec 31, 2017 ($90.8K) Mar 29, 2019
FY2017 Dec 31, 2016 ($89.3K) Mar 30, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($1.71M) Apr 1, 2026
FY2025 Dec 31, 2024 ($1.48M) Apr 1, 2026
FY2025 Dec 31, 2023 ($1.28M) Apr 1, 2026
FY2024 Dec 31, 2022 ($1.09M) Mar 20, 2025
FY2023 Dec 31, 2021 ($902.1K) Mar 15, 2024
FY2022 Dec 31, 2020 ($707.3K) Mar 28, 2023
FY2021 Dec 31, 2019 ($543.4K) Mar 24, 2022
FY2020 Dec 31, 2018 ($332.1K) Mar 26, 2021
FY2019 Dec 31, 2017 ($25.6K) Mar 27, 2020
FY2018 Dec 31, 2016 ($1.92M) Mar 29, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($298.75M) Apr 1, 2026
FY2025 Dec 31, 2024 ($298.52M) Apr 1, 2026
FY2024 Dec 31, 2023 ($298.31M) Mar 20, 2025
FY2023 Dec 31, 2022 ($298.12M) Mar 15, 2024
FY2022 Dec 31, 2021 ($297.94M) Mar 28, 2023
FY2021 Dec 31, 2020 ($297.74M) Mar 24, 2022
FY2020 Dec 31, 2019 ($297.58M) Mar 26, 2021
FY2019 Dec 31, 2018 ($297.37M) Mar 27, 2020
FY2018 Dec 31, 2017 ($297.06M) Mar 29, 2019
FY2017 Dec 31, 2016 ($296.67M) Mar 30, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.6K Apr 1, 2026
FY2025 Dec 31, 2024 $23.8K Apr 1, 2026
FY2024 Dec 31, 2023 $9.1K Mar 20, 2025
FY2023 Dec 31, 2022 $6.8K Mar 15, 2024
FY2022 Dec 31, 2021 $6.4K Mar 28, 2023
FY2021 Dec 31, 2020 $7.6K Mar 24, 2022
FY2020 Dec 31, 2019 $87.0K Mar 26, 2021
FY2019 Dec 31, 2018 $5.9K Mar 27, 2020
FY2018 Dec 31, 2017 $440 Mar 29, 2019
FY2018 Dec 31, 2016 $31.3K Mar 29, 2019

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Apr 1, 2026
FY2025 Dec 31, 2024 0 Apr 1, 2026

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Apr 1, 2026
FY2025 Dec 31, 2024 0 Apr 1, 2026

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 441.48M Apr 1, 2026
FY2025 Dec 31, 2024 441.48M Apr 1, 2026
FY2024 Dec 31, 2023 441.48M Mar 20, 2025
FY2023 Dec 31, 2022 441.48M Mar 15, 2024
FY2018 Dec 31, 2018 441.48M Mar 29, 2019
FY2018 Dec 31, 2017 441.48M Mar 29, 2019